Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting
dc.contributor.author | Kalamarides, M | |
dc.contributor.author | Acosta, MT | |
dc.contributor.author | Babovic-Vuksanovic, D | |
dc.contributor.author | Carpen, O | |
dc.contributor.author | Cichowski, K | |
dc.contributor.author | Gareth Evans, D | |
dc.contributor.author | Giancotti, F | |
dc.contributor.author | Oliver Hanemann, C | |
dc.contributor.author | Ingram, D | |
dc.contributor.author | Lloyd, AC | |
dc.contributor.author | Mayes, DA | |
dc.contributor.author | Messiaen, L | |
dc.contributor.author | Morrison, H | |
dc.contributor.author | North, K | |
dc.contributor.author | Packer, R | |
dc.contributor.author | Pan, D | |
dc.contributor.author | Stemmer-Rachamimov, A | |
dc.contributor.author | Upadhyaya, M | |
dc.contributor.author | Viskochil, D | |
dc.contributor.author | Wallace, MR | |
dc.contributor.author | Hunter-Schaedle, K | |
dc.contributor.author | Ratner, N | |
dc.date.accessioned | 2015-10-06T13:24:07Z | |
dc.date.available | 2015-10-06T13:24:07Z | |
dc.date.issued | 2012-03 | |
dc.identifier.issn | 0001-6322 | |
dc.identifier.issn | 1432-0533 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/3572 | |
dc.description.abstract |
The 2011 annual meeting of the Children's Tumor Foundation, the annual gathering of the neurofibromatosis (NF) research and clinical communities, was attended by 330 participants who discussed integration of new signaling pathways into NF research, the appreciation for NF mutations in sporadic cancers, and an expanding pre-clinical and clinical agenda. NF1, NF2, and schwannomatosis collectively affect approximately 100,000 persons in US, and result from mutations in different genes. Benign tumors of NF1 (neurofibroma and optic pathway glioma) and NF2 (schwannoma, ependymoma, and meningioma) and schwannomatosis (schwannoma) can cause significant morbidity, and there are no proven drug treatments for any form of NF. Each disorder is associated with additional manifestations causing morbidity. The research presentations described in this review covered basic science, preclinical testing, and results from clinical trials, and demonstrate the remarkable strides being taken toward understanding of and progress toward treatments for these disorders based on the close interaction among scientists and clinicians. | |
dc.format.extent | 369-380 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.language.iso | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.subject | Child | |
dc.subject | Genes, Neurofibromatosis 1 | |
dc.subject | Genes, Neurofibromatosis 2 | |
dc.subject | Humans | |
dc.subject | Meningioma | |
dc.subject | Neurilemmoma | |
dc.subject | Neurofibromatosis 1 | |
dc.subject | Neurofibromatosis 2 | |
dc.title | Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting | |
dc.type | journal-article | |
dc.type | Congress | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/22083253 | |
plymouth.issue | 3 | |
plymouth.volume | 123 | |
plymouth.publication-status | Published | |
plymouth.journal | Acta Neuropathologica | |
dc.identifier.doi | 10.1007/s00401-011-0905-0 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/Peninsula Medical School | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
plymouth.organisational-group | /Plymouth/Users by role/Researchers in ResearchFish submission | |
dc.publisher.place | Germany | |
dcterms.dateAccepted | 2011-10-31 | |
dc.identifier.eissn | 1432-0533 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1007/s00401-011-0905-0 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2012-03 | |
rioxxterms.type | Journal Article/Review |